絞り込み

16532

広告

Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry.

著者 Bergstra SA , Branco JC , Vega-Morales D , Salomon-Escoto K , Govind N , Allaart CF , Landewé RBM
Ann Rheum Dis.2018 Jul 06 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (2view , 0users)

Full Text Sources

To establish in a global setting the relationships between countries' socioeconomic status (SES), measured biological disease modifying antirheumatic drug (bDMARD)-usage and disease outcomes. To assess if prescription and reimbursement rules and generic access to medication relates to a countries' bDMARD-usage.
PMID: 29980576 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード